Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 293

1.

Antimicrobial properties of the equine alpha-defensin DEFA1 against bacterial horse pathogens.

Bruhn O, Cauchard J, Schlusselhuber M, Gelhaus C, Podschun R, Thaller G, Laugier C, Leippe M, Grötzinger J.

Vet Immunol Immunopathol. 2009 Jul 15;130(1-2):102-6. doi: 10.1016/j.vetimm.2009.01.005. Epub 2009 Jan 23.

PMID:
19211153
2.

Solution structure and functional studies of the highly potent equine antimicrobial peptide DEFA1.

Michalek M, Jung S, Shomali MR, Cauchard S, Sönnichsen FD, Grötzinger J.

Biochem Biophys Res Commun. 2015 Apr 17;459(4):668-72. doi: 10.1016/j.bbrc.2015.02.168. Epub 2015 Mar 11.

PMID:
25769951
3.

In vitro potential of equine DEFA1 and eCATH1 as alternative antimicrobial drugs in rhodococcosis treatment.

Schlusselhuber M, Jung S, Bruhn O, Goux D, Leippe M, Leclercq R, Laugier C, Grötzinger J, Cauchard J.

Antimicrob Agents Chemother. 2012 Apr;56(4):1749-55. doi: 10.1128/AAC.05797-11. Epub 2012 Jan 9.

4.

Acquired antimicrobial resistance in equine Rhodococcus equi isolates.

Boyen F, Pasmans F, Haesebrouck F.

Vet Rec. 2011 Jan 29;168(4):101a. doi: 10.1136/vr.c5289. Epub 2011 Jan 21. No abstract available.

PMID:
21257598
5.

In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.

Coleman M, Kuskie K, Liu M, Chaffin K, Libal M, Giguère S, Bernstein L, Cohen N.

Vet Microbiol. 2010 Nov 20;146(1-2):175-8. doi: 10.1016/j.vetmic.2010.05.027. Epub 2010 May 27.

PMID:
20554401
6.

The repertoire of equine intestinal alpha-defensins.

Bruhn O, Paul S, Tetens J, Thaller G.

BMC Genomics. 2009 Dec 23;10:631. doi: 10.1186/1471-2164-10-631.

7.

Activity of 10 antimicrobial agents against intracellular Rhodococcus equi.

Giguère S, Berghaus LJ, Lee EA.

Vet Microbiol. 2015 Aug 5;178(3-4):275-8. doi: 10.1016/j.vetmic.2015.05.019. Epub 2015 May 27.

PMID:
26051479
8.

Emergence of rifampin-resistant Rhodococcus equi in an infected foal.

Takai S, Takeda K, Nakano Y, Karasawa T, Furugoori J, Sasaki Y, Tsubaki S, Higuchi T, Anzai T, Wada R, Kamada M.

J Clin Microbiol. 1997 Jul;35(7):1904-8.

9.

A novel horse alpha-defensin: gene transcription, recombinant expression and characterization of the structure and function.

Bruhn O, Regenhard P, Michalek M, Paul S, Gelhaus C, Jung S, Thaller G, Podschun R, Leippe M, Grötzinger J, Kalm E.

Biochem J. 2007 Oct 15;407(2):267-76.

10.

Molecular characterization of Rhodococcus equi from horse-breeding farms by means of multiplex PCR for the vap gene family.

Monego F, Maboni F, Krewer C, Vargas A, Costa M, Loreto E.

Curr Microbiol. 2009 Apr;58(4):399-403. doi: 10.1007/s00284-009-9370-6. Epub 2009 Feb 10.

PMID:
19205798
11.
12.

[Characterization of Rhodococcus equi isolates from horse and man].

Fuhrmann C, Lämmler C.

Berl Munch Tierarztl Wochenschr. 1997 Feb;110(2):54-9. German.

PMID:
9139629
13.

Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.

Chaffin MK, Cohen ND, Martens RJ.

J Am Vet Med Assoc. 2008 Apr 1;232(7):1035-47. doi: 10.2460/javma.232.7.1035.

PMID:
18380623
14.

Appearance of multidrug-resistant virulent Rhodococcus equi clinical isolates obtained in China.

Liu H, Wang Y, Yan J, Wang C, He H.

J Clin Microbiol. 2014 Feb;52(2):703. doi: 10.1128/JCM.02925-13. Epub 2013 Dec 4. No abstract available.

15.

Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.

Berghaus LJ, Giguère S, Guldbech K.

Vet Microbiol. 2013 Oct 25;166(3-4):670-5. doi: 10.1016/j.vetmic.2013.07.006. Epub 2013 Jul 17.

PMID:
23915992
16.

Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia.

Kenney DG, Robbins SC, Prescott JF, Kaushik A, Baird JD.

Equine Vet J. 1994 May;26(3):246-8. No abstract available.

PMID:
8542848
17.

In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.

Giacometti A, Cirioni O, Kamysz W, Silvestri C, Del Prete MS, Licci A, D'Amato G, Lukasiak J, Scalise G.

J Antimicrob Chemother. 2005 Aug;56(2):410-2. Epub 2005 Jun 27.

PMID:
15983026
18.

Proteomic analysis and immunogenicity of secreted proteins from Rhodococcus equi ATCC 33701.

Barbey C, Budin-Verneuil A, Cauchard S, Hartke A, Laugier C, Pichereau V, Petry S.

Vet Microbiol. 2009 Mar 30;135(3-4):334-45. doi: 10.1016/j.vetmic.2008.09.086. Epub 2008 Oct 15.

PMID:
19019579
19.

Antimicrobial activity of truncated alpha-defensin (human neutrophil peptide (HNP)-1) analogues without disulphide bridges.

Lundy FT, Nelson J, Lockhart D, Greer B, Harriott P, Marley JJ.

Mol Immunol. 2008 Jan;45(1):190-3. Epub 2007 Jun 4.

PMID:
17548109
20.

In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.

Giguère S, Lee EA, Guldbech KM, Berghaus LJ.

Vet Microbiol. 2012 Nov 9;160(1-2):207-13. doi: 10.1016/j.vetmic.2012.05.031. Epub 2012 May 29.

PMID:
22704561

Supplemental Content

Support Center